Cargando…
LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma
SIMPLE SUMMARY: Glioblastoma is the most common adult malignant brain tumor. It is an aggressive tumor that returns even after surgical removal and temozolomide-based chemotherapy and radiation. Our goal was to understand what genes are altered by temozolomide and how those genes may contribute to t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759984/ https://www.ncbi.nlm.nih.gov/pubmed/33255632 http://dx.doi.org/10.3390/cancers12123505 |
_version_ | 1783627225216581632 |
---|---|
author | Baisiwala, Shivani Hall, Robert R. Saathoff, Miranda R. M. Shireman, Jack Park, Cheol Budhiraja, Shreya Goel, Chirag Warnke, Louisa Hardiman, Clare Wang, Jennifer Y. McCortney, Katy Horbinski, Craig M. Ahmed, Atique U. |
author_facet | Baisiwala, Shivani Hall, Robert R. Saathoff, Miranda R. M. Shireman, Jack Park, Cheol Budhiraja, Shreya Goel, Chirag Warnke, Louisa Hardiman, Clare Wang, Jennifer Y. McCortney, Katy Horbinski, Craig M. Ahmed, Atique U. |
author_sort | Baisiwala, Shivani |
collection | PubMed |
description | SIMPLE SUMMARY: Glioblastoma is the most common adult malignant brain tumor. It is an aggressive tumor that returns even after surgical removal and temozolomide-based chemotherapy and radiation. Our goal was to understand what genes are altered by temozolomide and how those genes may contribute to tumor return. Our work shows that one of the genes altered is LNX1, which increases the expression of Notch1, a gene important for glioblastoma progression. We further showed that the elevation of LNX1 and Notch1 results in an increase in the tumor stem cell population, a subpopulation of cells thought to help propagate a more aggressive tumor. Finally, we showed that forced reduction in LNX1 expression results in increased survival of animals implanted with glioblastoma. Together, these results suggest that LNX1 may be a novel therapeutic target that would allow modulation of Notch1 activity and the stem cell population, potentially resulting in increased patient survival. ABSTRACT: Glioblastoma (GBM) is the most common primary brain malignancy in adults, with a 100% recurrence rate and 21-month median survival. Our lab and others have shown that GBM contains a subpopulation of glioma stem cells (GSCs) that expand during chemotherapy and may contribute to therapeutic resistance and recurrence in GBM. To investigate the mechanism behind this expansion, we applied gene set expression analysis (GSEA) to patient-derived xenograft (PDX) cells in response to temozolomide (TMZ), the most commonly used chemotherapy against GBM. Results showed significant enrichment of cancer stem cell and cell cycle pathways (False Discovery Rate (FDR) < 0.25). The ligand of numb protein 1 (LNX1), a known regulator of Notch signaling by targeting negative regulator Numb, is strongly upregulated after TMZ therapy (p < 0.0001) and is negatively correlated with survival of GBM patients. LNX1 is also upregulated after TMZ therapy in multiple PDX lines with concomitant downregulations in Numb and upregulations in intracellular Notch1 (NICD). Overexpression of LNX1 results in Notch1 signaling activation and increased GSC populations. In contrast, knocking down LNX1 reverses these changes, causing a significant downregulation of NICD, reduction in stemness after TMZ therapy, and resulting in more prolonged median survival in a mouse model. Based on this, we propose that during anti-GBM chemotherapy, LNX1-regulated Notch1 signaling promotes stemness and contributes to therapeutic resistance. |
format | Online Article Text |
id | pubmed-7759984 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77599842020-12-26 LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma Baisiwala, Shivani Hall, Robert R. Saathoff, Miranda R. M. Shireman, Jack Park, Cheol Budhiraja, Shreya Goel, Chirag Warnke, Louisa Hardiman, Clare Wang, Jennifer Y. McCortney, Katy Horbinski, Craig M. Ahmed, Atique U. Cancers (Basel) Article SIMPLE SUMMARY: Glioblastoma is the most common adult malignant brain tumor. It is an aggressive tumor that returns even after surgical removal and temozolomide-based chemotherapy and radiation. Our goal was to understand what genes are altered by temozolomide and how those genes may contribute to tumor return. Our work shows that one of the genes altered is LNX1, which increases the expression of Notch1, a gene important for glioblastoma progression. We further showed that the elevation of LNX1 and Notch1 results in an increase in the tumor stem cell population, a subpopulation of cells thought to help propagate a more aggressive tumor. Finally, we showed that forced reduction in LNX1 expression results in increased survival of animals implanted with glioblastoma. Together, these results suggest that LNX1 may be a novel therapeutic target that would allow modulation of Notch1 activity and the stem cell population, potentially resulting in increased patient survival. ABSTRACT: Glioblastoma (GBM) is the most common primary brain malignancy in adults, with a 100% recurrence rate and 21-month median survival. Our lab and others have shown that GBM contains a subpopulation of glioma stem cells (GSCs) that expand during chemotherapy and may contribute to therapeutic resistance and recurrence in GBM. To investigate the mechanism behind this expansion, we applied gene set expression analysis (GSEA) to patient-derived xenograft (PDX) cells in response to temozolomide (TMZ), the most commonly used chemotherapy against GBM. Results showed significant enrichment of cancer stem cell and cell cycle pathways (False Discovery Rate (FDR) < 0.25). The ligand of numb protein 1 (LNX1), a known regulator of Notch signaling by targeting negative regulator Numb, is strongly upregulated after TMZ therapy (p < 0.0001) and is negatively correlated with survival of GBM patients. LNX1 is also upregulated after TMZ therapy in multiple PDX lines with concomitant downregulations in Numb and upregulations in intracellular Notch1 (NICD). Overexpression of LNX1 results in Notch1 signaling activation and increased GSC populations. In contrast, knocking down LNX1 reverses these changes, causing a significant downregulation of NICD, reduction in stemness after TMZ therapy, and resulting in more prolonged median survival in a mouse model. Based on this, we propose that during anti-GBM chemotherapy, LNX1-regulated Notch1 signaling promotes stemness and contributes to therapeutic resistance. MDPI 2020-11-25 /pmc/articles/PMC7759984/ /pubmed/33255632 http://dx.doi.org/10.3390/cancers12123505 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Baisiwala, Shivani Hall, Robert R. Saathoff, Miranda R. M. Shireman, Jack Park, Cheol Budhiraja, Shreya Goel, Chirag Warnke, Louisa Hardiman, Clare Wang, Jennifer Y. McCortney, Katy Horbinski, Craig M. Ahmed, Atique U. LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma |
title | LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma |
title_full | LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma |
title_fullStr | LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma |
title_full_unstemmed | LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma |
title_short | LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma |
title_sort | lnx1 modulates notch1 signaling to promote expansion of the glioma stem cell population during temozolomide therapy in glioblastoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759984/ https://www.ncbi.nlm.nih.gov/pubmed/33255632 http://dx.doi.org/10.3390/cancers12123505 |
work_keys_str_mv | AT baisiwalashivani lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT hallrobertr lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT saathoffmirandar lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT mshiremanjack lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT parkcheol lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT budhirajashreya lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT goelchirag lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT warnkelouisa lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT hardimanclare lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT wangjennifery lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT mccortneykaty lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT horbinskicraigm lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma AT ahmedatiqueu lnx1modulatesnotch1signalingtopromoteexpansionofthegliomastemcellpopulationduringtemozolomidetherapyinglioblastoma |